Apple
AAPL
Taylor Morrison Home
TMHC
D.R. Horton
DHI
Petroleo Brasileiro SA Petrobras
PBR
Vale SA
VALE
US Stock MarketDetailed Quotes
BSX Boston Scientific
- 100.800
- -1.540-1.50%
Close Mar 27 16:00 ET
- 100.640
- -0.160-0.16%
Post 20:01 ET
149.09BMarket Cap80.64P/E (TTM)
102.240High100.260Low7.61MVolume102.230Open102.340Pre Close768.37MTurnover0.52%Turnover Ratio80.64P/E (Static)1.48BShares107.17052wk High6.85P/B148.65BFloat Cap66.80052wk Low--Dividend TTM1.47BShs Float107.170Historical High--Div YieldTTM1.94%Amplitude4.790Historical Low100.959Avg Price1Lot Size
About Boston Scientific Company
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.
Company Profile
SymbolBSX
Company NameBoston Scientific
Listing DateMay 18, 1992
Issue Price17.00
Founded1979
CEOMr. Michael F. Mahoney
MarketNYSE
Employees53000
Fiscal Year Ends12-31
Address300 Boston Scientific Way
CityMarlborough
ProvinceMassachusetts
CountryUnited States of America
Zip Code01752-1234
Phone1-508-683-4000
Company Executives
- Name
- Position
- Salary
- Michael F. Mahoney
- Chairman of the Board, President and Chief Executive Officer
- 21.42M
- Miriam O’Sullivan
- Senior Vice President and Chief Human Resources Officer
- --
- Daniel J. Brennan
- Executive Vice President and Chief Financial Officer
- 6.69M
- Joseph M. Fitzgerald
- Executive Vice President and Group President, Cardiology
- 6.34M
- John Bradley Sorenson
- Executive Vice President, Global Operations
- --
- Jeffrey B. Mirviss
- Executive Vice President and President, Peripheral Interventions
- 4.03M
- Arthur C. Butcher
- Executive Vice President and Group President, MedSurg and Asia Pacific
- 5.01M
- Charles J. Dockendorff
- Independent Director
- 336.67K
- Senator John E. Sununu
- Independent Director
- 356.67K
- Susan E. Morano
- Independent Director
- 336.35K
- Ellen M. Zane
- Independent Director
- 356.67K
- Yoshiaki Fujimori
- Independent Director
- 351.67K
- Edward J. Ludwig
- Lead Independent Director
- 376.67K
- David S. Wichmann
- Independent Director
- 361.67K
- David C. Habiger
- Independent Director
- --
- Dr. Jessica L. Mega, M.D.,M.P.H.
- Independent Director
- 336.35K
- Dr. Cheryl B. Pegus, M.D.
- Independent Director
- 292.51K
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.